[HTML][HTML] Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?

M Faruk - Annals of Medicine and Surgery, 2021 - Elsevier
Chemotherapy is an essential treatment for breast cancer, inducing cancer cell death.
However, chemoresistance is a problem that limits the effectiveness of chemotherapy. Many …

Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: when, why and what?

R Torrisi, E Marrazzo, E Agostinetto… - Critical Reviews in …, 2021 - Elsevier
Indication for neoadjuvant chemotherapy (NACT) in HR+/HER2-negative tumors is
controversial. Pathological complete response (pCR) rates range from 0 to 18% while breast …

Capsaicin inhibits proliferation and induces apoptosis in breast cancer by down-regulating FBI-1-mediated NF-κB pathway

M Chen, C Xiao, W Jiang, W Yang, Q Qin… - Drug Design …, 2021 - Taylor & Francis
Background As a natural compound extracted from a variety of hot peppers, capsaicin has
drawn increasing attention to its anti-cancer effects against multiple human cancers …

[HTML][HTML] Metformin and breast cancer: where are we now?

M Cejuela, B Martin-Castillo, JA Menendez… - International journal of …, 2022 - mdpi.com
Breast cancer is the most prevalent cancer and the leading cause of cancer-related death
among women worldwide. Type 2 diabetes–associated metabolic traits such as …

Inhibition of Metastasis by Polypyridyl Ru(II) Complexes through Modification of Cancer Cell Adhesion – In Vitro Functional and Molecular Studies

I Gurgul, E Janczy-Cempa, O Mazuryk… - Journal of Medicinal …, 2022 - ACS Publications
The effect of polypyridyl Ru (II) complexes on the ability of cancer cells to migrate and
invade, two features important in the formation of metastases, is evaluated. In vitro studies …

Post-neoadjuvant treatment and the management of residual disease in breast cancer: state of the art and perspectives

R Caparica, M Lambertini, N Pondé… - … in medical oncology, 2019 - journals.sagepub.com
Achieving a pathologic complete response after neoadjuvant treatment is associated with
improved prognosis in breast cancer. The CREATE-X trial demonstrated a significant …

Perivascular stromal cells instruct glioblastoma invasion, proliferation, and therapeutic response within an engineered brain perivascular niche model

MT Ngo, JN Sarkaria, BAC Harley - Advanced Science, 2022 - Wiley Online Library
Glioblastoma (GBM) tumor cells are found in the perivascular niche microenvironment and
are believed to associate closely with the brain microvasculature. However, it is largely …

[HTML][HTML] Effect of neoadjuvant therapy on breast cancer biomarker profile

L Rey-Vargas, JC Mejía-Henao, MC Sanabria-Salas… - BMC cancer, 2020 - Springer
Background Breast cancer clinical management requires the assessment of hormone
receptors (estrogen (ER) and progesterone receptor (PR)), human epidermal growth factor …

[HTML][HTML] An automated breast volume scanner-based intra-and peritumoral radiomics nomogram for the preoperative prediction of expression of Ki-67 in breast …

Y Wu, Q Ma, L Fan, S Wu, J Wang - Academic Radiology, 2024 - Elsevier
Rationale and Objectives This study aimed to create and verify a nomogram for preoperative
prediction of Ki-67 expression in breast malignancy to assist in the development of …

[HTML][HTML] Quantification of Ki67 change as a valid prognostic indicator of luminal B type breast cancer after neoadjuvant therapy

S Tan, X Fu, S Xu, P Qiu, Z Lv, Y Xu… - Pathology and Oncology …, 2021 - por-journal.com
Introduction: Ki67 value and its variation before and after neoadjuvant chemotherapy are
commonly tested in relation to breast cancer patient prognosis. This study aims to quantify …